Hidenori Wake

Title: Hidenori Wake: Innovator in Neutrophil Activation Research

Introduction

Hidenori Wake is a prominent inventor based in Okayama, Japan. He has made significant contributions to the field of medical research, particularly in the area of neutrophil activation and its implications for various diseases. With a total of 2 patents, his work focuses on developing therapeutic agents and methods for predicting the severity of systemic inflammatory response syndrome (SIRS).

Latest Patents

Hidenori Wake's latest patents include innovative approaches to treating diseases caused by neutrophil activation. One of his notable inventions is a neutrophil activation regulator that comprises a histidine-rich glycoprotein (HRG). This invention aims to provide a therapeutic agent for SIRS and other inflammatory diseases. Additionally, he has developed methods for predicting the severity of SIRS by determining the blood level of HRG in affected subjects. His second patent also focuses on a therapeutic agent and inspection method for diseases caused by neutrophil activation, emphasizing the importance of HRG in these processes.

Career Highlights

Hidenori Wake is affiliated with Okayama University, where he conducts his research and development activities. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from inflammatory diseases. His innovative approaches have positioned him as a key figure in the medical research community.

Collaborations

Hidenori Wake has collaborated with notable colleagues, including Shuji Mori and Masahiro Nishibori. These partnerships have contributed to the advancement of research in neutrophil activation and its related therapeutic applications.

Conclusion

Hidenori Wake's contributions to the field of medical research, particularly in neutrophil activation, highlight his role as an influential inventor. His patents reflect a commitment to improving treatment methods for serious health conditions.